Discover
NTRB
Nutriband Inc.
3.09
2 x 2.23
2 x 3.95
bid
ask
-
0.10
3.13%
2 @ 04:00 PM
3.09 +0.00 (0.00%)
| Ytd | -31.94% | |
| 1y | -61.47% |
3.03
day range
3.29
2.90
52 week range
11.68
| Open | 3.19 | Prev Close | 3.19 | Low | 3.03 | High | 3.29 | Mkt Cap | 37.56M |
| Vol | 23.89K | Avg Vol | 10.72K | EPS | -2.56 | P/E | N/A | Forward P/E | -17.30 |
| Beta | 0.42 | Short Ratio | 1.53 | Inst. Own | 2.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-05 | 50-d Avg | 3.54 | 200-d Avg | 4.76 | 1yr Est | 18.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-12-03 | 2024-10 | 0 | -0.12 | N/A | N/A |
| 2024-09-03 | 2024-07 | 0 | -0.12 | N/A | N/A |
| 2024-05-31 | 2024-04 | 0 | -0.21 | N/A | N/A |
| 2024-04-30 | 2024-01 | 0 | -0.16 | N/A | N/A |
| 2023-12-12 | 2023-10 | 0 | -0.22 | N/A | N/A |
| 2023-09-11 | 2023-07 | 0 | -0.11 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2022-07-26 | Small Cap Consumer Research | Upgrade | Buy |
Profile
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-03-05 | MELNIK SERGUEI | President | 828.00K | Stock Gift |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 118.06K | 469.89K | 1.86% |
| 2024-09-29 | Geode Capital Management, LLC | 58.06K | 231.09K | 0.91% |
| 2024-09-29 | UBS Group AG | 20.35K | 81.00K | 0.32% |
| 2024-09-29 | Avantax Advisory Services, Inc. | 18.68K | 74.34K | 0.29% |
| 2024-09-29 | State Street Corporation | 17.27K | 68.72K | 0.27% |
| 2024-09-29 | Farther Finance Advisors, Llc | 16.01K | 63.74K | 0.25% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 71.58K | 284.87K | 1.13% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 43.79K | 174.28K | 0.69% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 29.33K | 116.75K | 0.46% |
| 2024-10-30 | Fidelity Total Market Index Fund | 9.88K | 39.33K | 0.16% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 7.26K | 28.89K | 0.11% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 6.72K | 26.74K | 0.11% |
Split
| Split | Date |
|---|---|
| 13 : 6 | 2022-08-15 |
| 116.667 : 100 | 2022-08-12 |
| 1 : 4 | 2019-07-24 |